Search research articles
Contact Us
Filters
Showing results (41-50 of 799) with videos related to
Page
of 80
Sort By:
JAMA Psychiatry
|
February 9, 2022
Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again?
Roy H Perlis, Maurizio Fava
Psychiatry (Edgmont (Pa. : Township))
|
September 1, 2010
Augmentation and combination strategies to treat the residual symptoms of major depressive disorder
Maurizio Fava, Steven D Targum
Psychotherapy and Psychosomatics
|
April 26, 2006
Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice
Maurizio Fava, A John Rush
European Psychiatry : the Journal of the Association of European Psychiatrists
|
April 10, 2007
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
George I Papakostas, Maurizio Fava
Seminars in Dialysis
|
March 18, 2005
Depression and renal disease
Eliana Tossani, Paolo Cassano, Maurizio Fava
Current Topics in Medicinal Chemistry
|
September 27, 2005
Is there a placebo problem in antidepressant trials?
Huaiyu Yang, Cristina Cusin, Maurizio Fava
Psychiatric Services (Washington, D.C.)
|
March 17, 2012
Major depressive disorder with psychosis-like symptoms among Latinos
Paolo Cassano, Maurizio Fava, David Mischoulon
The Journal of Clinical Psychiatry
|
January 7, 2011
Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach
Enrico Tedeschini, Maurizio Fava, George I Papakostas
The Journal of Clinical Psychiatry
|
January 27, 2005
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness
Maurizio Fava, Michael E Thase, Charles DeBattista
Journal of Clinical Pharmacology
|
February 23, 2016
Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Page
of 80
Search research articles
Search
Showing results (41-50 of 799) with videos related to
Sort By:
Page
of 80
JAMA Psychiatry
|
February 9, 2022
Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again?
Roy H Perlis, Maurizio Fava
Psychiatry (Edgmont (Pa. : Township))
|
September 1, 2010
Augmentation and combination strategies to treat the residual symptoms of major depressive disorder
Maurizio Fava, Steven D Targum
Psychotherapy and Psychosomatics
|
April 26, 2006
Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice
Maurizio Fava, A John Rush
European Psychiatry : the Journal of the Association of European Psychiatrists
|
April 10, 2007
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
George I Papakostas, Maurizio Fava
Seminars in Dialysis
|
March 18, 2005
Depression and renal disease
Eliana Tossani, Paolo Cassano, Maurizio Fava
Current Topics in Medicinal Chemistry
|
September 27, 2005
Is there a placebo problem in antidepressant trials?
Huaiyu Yang, Cristina Cusin, Maurizio Fava
Psychiatric Services (Washington, D.C.)
|
March 17, 2012
Major depressive disorder with psychosis-like symptoms among Latinos
Paolo Cassano, Maurizio Fava, David Mischoulon
The Journal of Clinical Psychiatry
|
January 7, 2011
Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach
Enrico Tedeschini, Maurizio Fava, George I Papakostas
The Journal of Clinical Psychiatry
|
January 27, 2005
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness
Maurizio Fava, Michael E Thase, Charles DeBattista
Journal of Clinical Pharmacology
|
February 23, 2016
Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone
Roberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Page
of 80